NextPoint is launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7/HHLA2 axis. Our team of proven drug developers is advancing an antibody-drug conjugate with our proprietary linker technology, a T-cell engager with wide therapeutic window, and a multi-functional checkpoint inhibitor. Our innovative approach integrates foundational science with a defined clinical biomarker to identify the right patient population for each B7-H7-directed modality, so that we can deliver first-in-class therapies to a broad range of cancer patients with B7-H7 upregulation including those who do not benefit from currently approved therapies such as PD-1/L1 inhibitors.
Company Details
- Employees
- 35
- Industry
- Biotechnology
- Website
- http://www.nextpointtx.com
- Keywords
- Manager jobs.
Nextpoint Therapeutics, Inc. Questions
Nextpoint Therapeutics, Inc.'s website is http://www.nextpointtx.com
Nextpoint Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nextpoint-therapeutics
Nextpoint Therapeutics, Inc. has
35 employees.
View email and phone details for 35
employees at Nextpoint Therapeutics, Inc..
Nextpoint Therapeutics, Inc.'s industry is
Biotechnology
Nextpoint Therapeutics, Inc.'s top competitors are
Neurona Therapeutics,
Frontier Medicines,
Curve Therapeutics,
Verseau Therapeutics,
Firefly Bio,
Areteia Therapeutics,
Latigo Biotherapeutics, Inc.,
Marengo Therapeutics,
Aera Therapeutics,
Kenai Therapeutics.
Nextpoint Therapeutics, Inc.'s categories are Biotechnology
